THE first continuous glucose monitoring system for adults 18+ years living with diabetes has been approved by the US Food and Drug Administration (FDA).
Named the FreeStyle Libre Flash Glucose Monitoring System from Abbott Diabetes Care, the system requires no calibration by a fingerprick blood test and can be used by adult patients to make diabetes treatment decisions.
The system reduces the need for fingerstick testing by using a small sensor wire inserted below the skin's surface that continuously measures and monitors glucose levels, and can be worn for up to 10 days, the FDA said.
Users determine glucose levels by waving a dedicated mobile reader (pictured) above the sensor wire to determine if glucose levels are too high (hyperglycemia) or too low (hypoglycemia), and how glucose levels are changing.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Oct 17
